Sustainme.in reports the fashion brands are trimming extended size ranges, citing falling demand as Ozempic and similar drugs spread in the West.
Recap by typeshit. Post by sustainme.in® on X.
A Facebook post credits Novo Nordisk's GLP-1 drugs with strong results in obesity and type 2 diabetes, plus lower risk of other conditions.
Lilly's tirzepatide shot Zepbound now has FDA approval in a KwikPen format for weight management. Tap through for details on the new pen.
At the SIO congress in Palermo, specialists flagged short real-world adherence and no national reimbursement in Italy. Oral semaglutide and orforglipron are expected there in 2027.
Polish pharmacy platform GdziePoLek says, citing the manufacturer, that the first Oral Wegovy shipment should arrive soon. No exact launch date is set yet.
A short clip of Rosie O'Donnell discussing the tirzepatide drug Mounjaro. Few details are given beyond the title.
Sinclair told Joe Rogan GLP-1 drugs could double the risk of sudden vision loss. Dr. Tatem says the figures Sinclair cited do come from real data.
Loading…